Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Jun Tang(Hubei University of Medicine), Xiao‐Feng Zhu(Sun Yat-sen University), Shan Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jianhua Fu(Hefei University of Technology), Zi-Ming Du(Sun Yat-sen University), Ming-Tian Yang(Sun Yat-sen University Cancer Center), Rong-Zhen Luo(Sun Yat-sen University Cancer Center), Mu-Yan Cai(Sun Yat-sen University), Guo-Ping Shen(Sun Yat-sen University), Rong Deng(Sun Yat-sen University)
Breast Cancer Research and Treatment
May 14, 2012
10.1007/s10549-012-2080-y
Cited by 69

Related Papers

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
|Molecular Cancer|2019|549
ecDNA hubs drive cooperative intermolecular oncogene expression
|Nature|2021|334
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
|Autophagy|2017|275
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells
|Oncogene|2008|257
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229